Once Upon a Time in Harlem Oscar Odds Fall to 12% in Three Days
The former frontrunner lost nearly half its probability with no news catalyst, dropping it into a three-way tie behind American Doctor at 16%.
Bottom line
Traders cut the former frontrunner nearly in half. American Doctor now leads at 16%, with three films packed within four points.
- Market average
- 5% YES
- Best listed price
- 7¢ · Polymarket
Once Upon a Time in Harlem's Oscar Documentary Chances Drop to 12% With No Confirmed Catalyst
Once Upon a Time in Harlem, which entered the week as the consensus frontrunner for Best Documentary Feature Film at the 99th Academy Awards, now trades at 12% on Kalshi and 11% on Polymarket, down from 22% three days ago. That 10-percentage-point decline dropped it from clear leader to a tie for second behind American Doctor, which holds 16%.
No confirmed news event, disqualification, distribution change, or scandal has surfaced to explain the move. A review of press coverage from the past 72 hours turned up nothing directly tied to the film: no withdrawal, no critical backlash, no rival breakout at a festival. The absence of a catalyst is itself the story. This looks like a market that priced in credentials too early and is now unwinding that premium.
Prediction-market view
Live prices, venue by venue
Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.
Once Upon a Time in Harlem
Consensus YES price across 2 venues
One in a Million
Consensus YES price across 2 venues
Tutu
Consensus YES price across 2 venues
Nuisance Bear
Consensus YES price across 2 venues
Current new-user offer · Kalshi
Get a $35 trading bonusCode PRED35
New users only. Eligibility restrictions and terms apply.
Before diagnosing why this happened, it helps to understand what made Once Upon a Time in Harlem the frontrunner in the first place, and how strong those credentials actually were.
Why Once Upon a Time in Harlem Was the 2027 Best Documentary Oscar Frontrunner
The bull case for this film rested on four pillars, each a genuine marker of awards-season viability. First, the documentary premiered at the 2026 Sundance Film Festival, which over the past decade has been the single most productive launchpad for eventual Best Documentary nominees. Second, Neon acquired U.S. distribution rights in February 2026, giving the film the same distributor that shepherded past winners through the campaign gauntlet.
Third, the film received the Albie Award from the Maysles Documentary Center in August 2026, a recognition of its contribution to nonfiction filmmaking that carried curatorial weight. Fourth, it earned a finalist slot for the Library of Congress Lavine/Ken Burns Prize, a distinction that signals institutional respect beyond the festival circuit.
Directed by William Greaves and David Greaves, the documentary carried both critical credibility and distributor muscle. In a normal year, that combination would sustain frontrunner status through the fall festival circuit. The market clearly agreed: 22% in a multi-candidate field is a commanding position, typically reserved for films with at least one precursor win already recorded.
Yet none of those four credentials changed in the past week. They remain exactly as strong, or as weak, as they were on Monday.
The Case Against Once Upon a Time in Harlem: Credentials Are Not Votes
Here is where the strongest counter-argument deserves full weight. Sundance premieres, distributor deals, and curatorial prizes are inputs. They are not votes. The Academy's documentary branch has a well-documented history of passing over frontrunners who peak too early. Films that dominate the September conversation often fade once the shortlist narrows in December, replaced by late-breaking entries from fall festivals or theatrical releases that build grassroots campaigning momentum.
The 2026 ceremony offered a case study: Mr. Nobody Against Putin won Best Documentary at the 98th Academy Awards, a film that was not the pre-season consensus pick. The documentary branch consistently rewards topicality and emotional impact over pedigree, and the fall festival season has barely begun. Venice just hosted new documentary premieres, and Toronto and New York are still ahead. Any one of those festivals could introduce a challenger that resets the field.
The market's correction may simply reflect this structural reality: a 22% price in September, six months before the ceremony, was always pricing in certainty that does not exist in documentary races.
2027 Oscar Documentary Race Standings: American Doctor Takes the Lead in a Tightening Field
American Doctor now holds the top position at 16%. Once Upon a Time in Harlem and One in a Million are tied at roughly 12%, with slight platform variation (Kalshi has Once Upon a Time in Harlem at 12%, Polymarket at 11%). The entire top three is compressed within four percentage points, a spread so narrow that a single IDA screening, a National Board of Review citation, or a Critics Choice Documentary nomination could reorder the leaderboard overnight.
This compression matters for traders evaluating entry points. When the frontrunner sits at 16% in a multi-candidate field, the market is effectively saying no one has separated from the pack. That is a fundamentally different signal than the one the market was sending three days ago, when Once Upon a Time in Harlem's 22% price implied at least a modest separation.
The resolution date of March 14, 2027 is still six months away. The shortlist announcement, the nomination morning, and the final voting window are all ahead. Each of those checkpoints has historically produced double-digit probability swings in the documentary category.
Once Upon a Time in Harlem Price Chart: What Three Days of Selling Looks Like
The trajectory from 22% to a period low of 10% before recovering to 12% tells a specific story. This was not a gradual fade driven by accumulating doubt. The film lost roughly half its value and then found a floor, a pattern consistent with a repricing event rather than slow erosion. Traders who entered at the peak are now holding a position worth less than half what they paid in under a week.
The 1-percentage-point spread between Kalshi (12%) and Polymarket (11%) is tight enough to confirm that both platforms are reflecting the same consensus, not a platform-specific anomaly.
For anyone tracking the full field and live prices, the Oscar Winner: Best Documentary Feature Film odds page has the complete breakdown across all candidates and platforms.
What This Means for the 2027 Oscar Documentary Race
The core takeaway is structural, not specific to one film. The Best Documentary Feature Film race is genuinely open. A 16% leader in September means the market assigns an 84% probability that someone other than American Doctor wins. Once Upon a Time in Harlem's credentials remain real, but the market has recalibrated what those credentials are worth this far from the ceremony.
If a fall festival produces a breakout documentary, these prices will move again. If Once Upon a Time in Harlem lands a shortlist spot in December and picks up a DGA or PGA documentary nomination, the 12% price will look like a buying opportunity in retrospect. The information that matters most for this race has not been generated yet. The market is pricing that uncertainty correctly for the first time this cycle.
Join our Discord for breaking news alerts, driven by real-time movements in prediction markets.
The story so far: Oscar Winner: Best Documentary Feature Film
4 updates · Sep 4 – Sep 19
Free Trading Tools
View allCompare fees across Kalshi, Polymarket & PredictIt.
Find fair probabilities with the overround removed.
See if a trade has positive EV before you enter.
Convert American, decimal & implied probability.
Combined odds and payouts for multi-leg bets.
Your real take-home after fees and taxes.

Trade YES at 7¢